# Hypofraction Radiotherapy for Locally Advanced Non-small Cell Lung Cancer

> **NCT05269485** · PHASE1,PHASE2 · RECRUITING · sponsor: **Anhui Provincial Hospital** · enrollment: 36 (estimated)

## Conditions studied

- Toxicity Due to Radiotherapy
- Non-small Cell Lung Cancer

## Interventions

- **RADIATION:** High-dose fractionated radiotherapy
- **RADIATION:** Low-dose fractionated radiotherapy

## Key facts

- **NCT ID:** NCT05269485
- **Lead sponsor:** Anhui Provincial Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-08-01
- **Primary completion:** 2024-12-01
- **Final completion:** 2024-12-01
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2024-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05269485

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05269485, "Hypofraction Radiotherapy for Locally Advanced Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05269485. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*